QUININE
이 기록은 EU 화장품 표시에 사용하는 공식 일반 원료 명칭을 확인해 줍니다. 그것만으로는 해당 물질이 허용되거나 제한이 없거나 안전하다는 것이 확인되지 않습니다.
글로벌 근거 요약
확인된 정체는 색인된 시장 데이터세트 13개 중 8개에서 일치하는 규제 근거가 있습니다: 국가 기록 7건과 EU 부속서 기록 1건. 모든 결과와 근거 부족 사항은 아래에 나열되어 있습니다.
확인된 물질 정체
Cinchonan-9-ol, 6'-methoxy-, (8.alpha., 9R)-
목록 제한 사항 주석: III/21
일치 또는 보고된 명칭 9개
13개 시장 전체의 규제 근거
일치하는 각 기록을 열어 범위, 농도, 조건, 경고 문구 및 공식 출처 버전을 확인하세요.
데이터세트 범위와 다음 조치를 보려면 가로로 스와이프하거나 스크롤하세요.
| 시장 | 결과 | 기록 | 데이터세트 | 의미 / 다음 조치 |
|---|---|---|---|---|
| European Union EU | 사용제한 | 1기록 열기 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| Great Britain GB | Restricted | 1기록 열기 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| Canada CA | 일치하는 항목 없음 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Restricted | 1기록 열기 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| ASEAN ASEAN | Restricted | 1기록 열기 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| China CN | 일치하는 항목 없음 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 일치하는 항목 없음 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Restricted | 1기록 열기 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| United States US | 일치하는 항목 없음 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | Restricted | 1기록 열기 1 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| Brazil BR | 일치하는 항목 없음 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1기록 열기 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 연결된 모든 기록과 정확한 조건을 검토하세요. |
| Saudi Arabia SA | Restricted | 1기록 열기 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 연결된 모든 기록과 정확한 조건을 검토하세요. |
일치하는 시장 기록 및 조건
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026Australia
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026정확히 일치하는 부속서 II–VI 근거
QUININE
제품 범위: (a) Hair rinse-off products (b) Hair leave-on products
최대 농도: (a) 0.5% (as quinine base) (b) 0.2% (as quinine base)
화학적 정체 및 특성

Quinine
Quinine is a cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. It has a role as a non-narcotic analgesic, an antimalarial and a muscle relaxant. It is a conjugate base of a quinine(1+). It derives from a hydride of an (8S)-cinchonan. — ChEBI
- IUPAC 명칭
- (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
- 분자식
- C20H24N2O2
- 분자량
- 324.4 g/mol
- 정확한 질량
- 324.183778013 Da
- XLogP3
- 2.9
- 위상 극성 표면적
- 45.6 Ų
- 수소 결합 공여체
- 1
- 수소 결합 수용체
- 4
- 공유결합 단위
- 1
- 정의된 입체중심
- 4
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
추가 과학 데이터베이스의 근거
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Triboluminescent, orthorhombic needles from absolute alcohol 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: Bulky, white, amorphous powder or crystalline alkaloid 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: CRYSTALS TURN BROWN ON EXPOSURE TO AIR 출처: Hazardous Substances Data Bank (HSDB)
- Basic pKa: 8.56 출처: ChEMBL
- Basic pKa: 8.55 출처: ChEMBL
- Dissociation Constants: pK1 (18 °C) = 5.07; pK2 = 9.7 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 3.44 출처: DrugBank
- LogP: log Kow = 3.44 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 2.6 출처: Human Metabolome Database (HMDB)
- Melting Point: 57 °C 출처: DrugBank
- Melting Point: 177 °C (some decomposition) 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: Microcrystalline powder; mp: 57 °C; efflorescent; loses one water molecule in air, two water molecules over sulfuric acid; anhydrous at 125 °C /Quinine trihydrate/ 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: 57 °C 출처: Human Metabolome Database (HMDB)
- Odor: ODORLESS 출처: Hazardous Substances Data Bank (HSDB)
- Physical Description: Solid 출처: Human Metabolome Database (HMDB)
- Refractive Index: INDEX OF REFRACTION: 1.625 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 500 mg/L (at 15 °C) 출처: DrugBank
- Solubility: In water, 500 mg/L at 15 °C 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 1900 mL water, 760 mL boiling water 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 80 mL benzene (18 mL at 50 °C), 1.2 mL chloroform, 250 mL dry ether, 20 mL glycerol, 0.8 mL alcohol, 1900 mL of 10% ammonia water; almost insoluble in petroleum ether 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in ether, chloroform, carbon disulfide, glycerol, alkalies, and acids (with formation of salts) 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Sol in pyrimidine 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 3.34e-01 g/L 출처: Human Metabolome Database (HMDB)
- pH: pH of saturated aqueous solution = 8.8 출처: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 출처: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral 출처: Toxin and Toxin Target Database (T3DB)
- Signal: Danger 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (22.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (28.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (99.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (28.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334 (83.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 201 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Signal: Warning 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Signal: Danger 출처: Hazardous Substances Data Bank (HSDB)
- GHS Hazard Statements: H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 출처: Hazardous Substances Data Bank (HSDB)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 출처: Hazardous Substances Data Bank (HSDB)
- Health Effects: It is usual for quinine in therapeutic doses to cause cinchonism; in rare cases, it may even cause death (usually by pulmonary edema). Quinine can worsen hemoglobinuria, myasthenia gravis and optic neuritis. It can cause paralysis if accidentally injected into a nerve, and is extremely toxic in overdose[Wikipedia] 출처: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: IDENTIFICATION AND USE: Quinine is a bulky, white, amorphous powder or crystalline alkaloid, used as medication: non-narcotic analgesics; antimalarial; central muscle relaxants. It is also used as flavor in carbonated beverages. HUMAN EXPOSURE AND TOXICITY: Serious hypersensitivity reactions, including anaphylactic shock, anaphylactoid reactions, urticaria, serious skin rashes, angioedema, facial edema, bronchospasm, and pruritus, have been reported with quinine. In addition, thrombocytopenia, hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP), immune thrombocytopenic purpura, blackwater fever, disseminated intravascular coagulation, leukopenia, neutropenia, granulomatous hepatitis, and acute interstitial nephritis have been reported and may also be due to hypersensitivity reactions to the drug. Potentially fatal cardiac arrhythmias, including torsades de pointes and ventricular fibrillation, have been reported rarely during quinine therapy. At least 1 case of fatal ventricular arrhythmia has been reported in a geriatric patient with preexisting prolonged QT interval treated with IV quinine sulfate for Plasmodium falciparum malaria. Visual impairment can range 출처: Hazardous Substances Data Bank (HSDB)
- Toxicity Summary: The theorized mechanism of action for quinine and related anti-malarial drugs is that these drugs are toxic to the malaria parasite. Specifically, the drugs interfere with the parasite's ability to break down and digest hemoglobin. Consequently, the parasite starves and/or builds up toxic levels of partially degraded hemoglobin in itself. 출처: Toxin and Toxin Target Database (T3DB)
- Uses: Medicine (antimalarial) as the alkaloid or as numerous salts and derivatives; flavoring in carbonated beverages 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Flavor in carbonated beverages. 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION (VET) 출처: Hazardous Substances Data Bank (HSDB)
- Uses: For more Uses (Complete) data for QUININE (8 total), please visit the HSDB record page. 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >5000; Use (kg) in USA (2002): 56800; Consumption (g per capita; approx.) in Germany (2009): 0.0611; Consumption (g per capita) in the USA (2002): 0.201; Calculated removal (%): 41.8 출처: NORMAN Suspect List Exchange
- Uses: For the treatment of malaria and leg cramps. Used as an antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory. It is also used as a flavor component of tonic water and bitter lemon. 출처: Toxin and Toxin Target Database (T3DB)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.
추가 공신력 있는 물질 조사
각 링크는 해당 출처에서 이 정체를 검색합니다. 링크는 조사 경로일 뿐이며, 그 출처에 정확히 일치하는 기록이 있다는 주장이 아닙니다. 각 출처의 성격과 법적 비중
공식 출처 및 범위
집행위원회 시행결정 (EU) 2025/1175(데이터세트 버전 EU 2025/1175)에서 가져왔습니다. 이 용어집은 제19조 제1항 (g)호에서 요구하는 성분 목록에 사용할 일반 원료 명칭을 제공하며, 승인 또는 안전성 목록이 아닙니다.
공식 결정 열기